Jade Biosciences, Inc. (JBIO) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jade Biosciences, Inc. on December 13, 2025. The filing reports the entry into a Material Definitive Agreement regarding a private placement of equity securities. The Company is an emerging growth company incorporated in Nevada with principal executive offices in Waltham, MA.
Key Financial Metrics and Transaction Details
- Transaction Type: Private placement of common stock.
- Shares Issued: 3,214,286 shares of Common Stock.
- Price Per Share: $14.00.
- Gross Proceeds: Approximately $45 million (before offering expenses).
- Expected Closing Date: December 16, 2025.
- Use of Proceeds: Funding research and development, general corporate expenses, and working capital needs.
Note: This filing does not provide historical revenue, profit, cash flow, margin, or debt metrics. It focuses solely on the capital raise transaction.
Material Changes and Agreements
On December 13, 2025, the Company entered into a Securities Purchase Agreement and a Registration Rights Agreement with an accredited investor or qualified institutional buyer. Key terms include:
- Registration Rights: The Company must file a registration statement for the resale of shares within 45 days of closing and use reasonable best efforts to have it declared effective within 75 days thereafter.
- Exemptions: The offering is exempt from registration under Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D.
- Conditions: Closing is subject to customary conditions.
Outlook, Risks, and Management Commentary
Management intends to utilize the net proceeds to support R&D and operational liquidity. The filing includes standard forward-looking statements cautioning that actual results may differ due to market conditions and the satisfaction of closing conditions. The Company directs investors to its Form 10-K for a comprehensive list of risk factors.
Investor Verification Checklist
- Verify the final closing of the transaction on or around December 16, 2025.
- Confirm the identity of the Purchaser once disclosed in subsequent filings.
- Monitor the filing of the registration statement for resale of shares within the 45-day post-closing window.
- Review the Company's most recent Form 10-K for current liquidity status and burn rate to assess the impact of the $45 million raise.
- Check for any offering expenses that may reduce the net proceeds below the $45 million gross figure.